Trellus Health plc (TRLS.L)
LSE · GBp · Healthcare · Health Information Services
£0.12 (+0.00%) as of
Key statistics
- Market cap
- 516.14k
- Forward P/E
- -0.00
- EPS (TTM)
- -0.0400
- Dividend yield
- 0.00%
- 52-week range
- 0.0012 – 2.3360
- Beta
- 2.53
- Revenue (TTM)
- 359k
- Profit margin
- 0.00%
- Volume
- 2.80M
About Trellus Health plc
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn's Disease and ulcerative colitis. The company was incorporated in 2020 and is headquartered in White Plains, New York.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- White Plains, NY, United States
- Employees
- 18
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- SCHRODER BSC SOCIAL IMPACT TRUS (SBSI.L)
- ALTITUDE GROUP PLC ORD 0.4P (ALT.L)
- LITIGATION CAPITAL MANAGEMENT L (LIT.L)
- KONINKLIJKE PHILIPS NV KONINKLI (0LNG.IL)
- CADENCE MINERALS PLC ORD 1P (KDNC.L)
- EUROFINS SCIENTIFIC SE EUROFINS (0MV5.IL)
- ONWARD OPPORTUNITIES LIMITED OR (ONWD.L)
- ROQUEFORT THERAPEUTICS PLC ORD (ROQ.L)